References
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders5th edArlington, VA, USAAmerican Psychiatric Association2013
- PolanczykGde LimaMSHortaBLBiedermanJRohdeLAThe worldwide prevalence of ADHD: a systematic review and metaregression analysisAm J Psychiatry200716494294817541055
- HarpinVMazzoneLRaynaudJPKahleJHodgkinsPLong-term outcomes of ADHD: a systematic review of self-esteem and social functionJ Atten Disord5222013 [Epub ahead of print]
- BiedermanJPettyCRWoodworthKYLomedicoAHyderLLAdult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up studyJ Clin Psychiatry20127394195022901345
- BarbaresiWJColliganRCWeaverALVoigtRGKillanJMKatusicSKMortality, ADHD, and psychosocial adversity in adults with childhood ADHDPediatrics201313163764423460687
- EspositoMGallaiBParisiLVisuomotor competencies and primary monosymptomatic nocturnal enuresis in prepubertal aged childrenNeuropsychiatr Dis Treat2013992192623847418
- Cohen-ZionMAnconi-IsraelSSleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studiesSleep Med Rev2004837940215336238
- EspositoMAntinolfiLGallaiBExecutive dysfunction in children affected by obstructive sleep apnea syndrome: an observational studyNeuropsychiatr Dis Treat201391087109423976855
- EspositoMCarotenutoMBorderline intellectual functioning and sleep: the role of cyclic alternating patternNeurosci Lett2010485899320813159
- BiedermanJFaraoneSVAttention-deficit hyperactivity disorderLancet200536623724816023516
- PliszkaSAACAP Working Group on Quality IssuesPractice parameters for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry20074689492117581453
- Canadian Attention Deficit Hyperactivity Disorder Resource AlliancePractice GuidelinesToronto, ON, CanadaCanadian Attention Deficit Hyperactivity Disorder Resource2010
- National Institute for Health and Care ExcellenceAttention deficit hyperactivity disorder (CG72) Available from: http://www.nice.org.uk/CG072Accessed January 23, 2014
- MontoyaAColomFFerrinMIs psychoeducation for parents and teachers of children and adolescents with ADHD efficacious? A systematic literature reviewEur Psychiatry20112616617521292454
- DemidovichMKolkoDJBuksteinOGHartJMedication refusal in children with oppositional defiant disorder or conduct disorder and co-morbid attention-deficit/hyperactivity disorder: medical history and clinical correlatesJ Child Adolesc Psychopharmacol201121576621288119
- CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health200811444718237359
- BarnerJCKhozaSOladapoAADHD medication use, adherence, persistence and cost among Texas Medicaid childrenCurr Med Res Opin201127Suppl 2132221973228
- LawsonKAJohnsrudMHodgkinsPSasaneRCrismonMLUtilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid programClin Ther20123494495622444786
- LachaineJBeaucheminCSasaneRHodgkinsPSTreatment patterns, adherence, and persistence in ADHD: a Canadian perspectivePostgrad Med201212413914822691908
- FaberAKalverdijkLJde Jong-van den BergLTWHugtenburgJGMinderaaRBTobiHParents report on stimulant-treated children in the Netherlands: initiation of treatment and follow-up careJ Child Adolesc Psychopharmacol20061643244016958568
- ColettiDJPappadopulosEKatsiotasNJBerestAJensenPSKafantarisVParent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol20122222623722537185
- ChanPWDeBruyneJAParental concern towards the use of inhaled therapy in children with chronic asthmaPediatr Int20004254755111059547
- SteinhoffKWAttention-deficit/hyperactivity disorder: medication treatment-dosing and duration of actionAm J Manag Care2004104 SupplS99S10615352536
- SvanborgPTherlundGGustafssonPAHägglöfBPooleLKadesjöBEfficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorderEur Child Adolesc Psychiatry20091824024919156355
- Rummel-KlugeCKlugeMKisslingWFrequency and relevance of psychoeducation in psychiatric diagnoses: results of two surveys five years apart in German-speaking European countriesBMC Psychiatry20131317023777594
- ChuangJHHripcsakGHeitjanDFDesign and analysis of controlled trials in naturally clustered environments: implications for medical informaticsJ Am Med Inform Assoc2002923023811971884
- BarkleyRAPsychosocial treatments for attention-deficit/hyperactivity disorder in childrenJ Clin Psychiatry200263Suppl 12364312562060
- National Institute for Health and Care ExcellenceMethylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents Available from: http://www.nice.org.uk/nicemedia/pdf/ta098guidance.pdfAccessed January 23, 2014
- DuPaulGJPowerTJAnastopoulosADReidRADHD Rating Scale-IV Checklist, Norms, and Clinical InterpretationsNew York, NY, USAGuilford Press1998
- GuyWECDEU Assessment Manual for Psychopharmacology, RevisedBethesda, MD, USAUS Department of Health, Education, and Welfare1976
- WeissMDWeissJRA guide to the treatment of adults with ADHDJ Clin Psychiatry200465Suppl 3273715046533
- QuintanaHKelseyDKCherlinEATransition from psychostimulants to atomoxetine in pediatric and adolescent patients with attention-deficit/hyperactivity disorderAbstract P8.061 presented at the 18th European College of Neuropsychopharmacology CongressOctober 22–26, 2005Amsterdam, The Netherlands
- DicksonRALeeBTurgayAChange in ADHD symptoms during 1 year of atomoxetine treatmentPresented at the 57th Annual Conference of the Canadian Psychiatric AssociationNovmber 15–18, 2007Montreal, QC, Canada
- XieTWaksmanJDesign and sample size estimation in clinical trials with clustered survival times as the primary endpointStat Med2003222835284612953283
- CampbellMKElbourneDAltmanDCONSORT statement: extension to cluster randomised trialsBMJ200432870270815031246
- KaplanELMeierPNonparametric estimation from incomplete observationsJ Am Stat Assoc195853457481
- LinDYCox regression analysis of multivariate failure time data: the marginal approachStat Med199413223322477846422
- AlderLDNierenbergAAReview of medication adherence in children and adults with ADHDPostgrad Med201012218419120107302
- HodgkinsPSasanéRChristensenLHarleyCLiuFTreatment outcomes with methylphenidate formulations among patients with ADHD: retrospective analysis of a managed care populationCurr Med Res Opin201127Suppl 2536221973231
- MarcusSCDurkinMStimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry20115048048921515197
- CaisleyHMűllerUAdherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: a systematic reviewEur Psychiatry20122734334922521805
- HugtenburgJGWitteIHeerdinkERDeterminants of compliance with methylphenidate therapy in childrenActa Paediatr2006951674167617129982
- ToomeySLSoxCMFinkelsteinJAWhy do children with ADHD discontinue treatment?Clin Pediatr (Phila)20125176376922584541
- KooijJJRősslerMPhilipsenAPredictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized placebo-controlled trialBMC Psychiatry2013133623347693
- TakonLClinical use of a modified release methylphenidate in the treatment of childhood attention deficit hyperactivity disorderAnn Gen Psychiatry2011102521962224
- ThyiruchelvamDCharachASchacharRJModerators and mediators of long-term adherence to stimulant treatment in children with ADHDJ Am Acad Child Adolesc Psychiatry20014092292811501692
- AtzoriPUsalaTCarucciSDanjouFZuddasAPredictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic studyJ Child Adolesc Psychopharmacol20091967368120035585